{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:17:30Z","timestamp":1783430250846,"version":"3.54.6"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["BCRF 24-028"],"award-info":[{"award-number":["BCRF 24-028"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation for Barnes-Jewish Hospital and by Siteman Cancer Center"},{"name":"National Cancer Institute (NCI) Cancer Center","award":["P30CA091842"],"award-info":[{"award-number":["P30CA091842"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32CA190194"],"award-info":[{"award-number":["T32CA190194"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The association between histological subtypes of benign breast disease and subsequent breast cancer risk in the postmammography era of increased benign breast disease detection requires continued study to inform the clinical management of high-risk women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We identified a cohort of 8915 women diagnosed with histologically confirmed benign breast lesions between 2010 and 2023 from the Joanne Knight Breast Health Center in St. Louis. Risk of subsequent breast events after a benign breast biopsy was assessed with Cox regression to estimate hazard ratios (HRs) and 95% confidence intervals (95% CIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Within a median follow-up of 6.5\u2009years, 363 women developed breast cancer. The cohort was 63.7% White, 32.4% Black, and 3.9% Asian race. Breast cancer risk increased across subtypes of benign breast disease, from proliferative disease without atypia to atypical hyperplasia, with atypical hyperplasia risk modified by time since biopsy and menopause. Compared with women with nonproliferative disease, age-adjusted risk for breast cancer was 1.69 for proliferative disease without atypia (HR\u2009= 1.69,\u200995% CI\u2009=\u20091.35 to 2.12) and 2.78 for atypical hyperplasia (HR\u2009=\u20092.78, 95% CI = 2.01 to 3.85; P &amp;lt; .0001 for trend). Risk estimates attenuated but remained similar in fully adjusted models. Risks associated with benign breast disease subtypes were similar for Black and White women, but Black women with atypical hyperplasia had greater risk of breast cancer since recent biopsy (\u22644\u2009years) and during the premenopausal period (P = .033 for heterogeneity).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Breast cancer risk increases with the degree of epithelial proliferation, highest in atypical hyperplasia, amplified by recent biopsy and premenopause, particularly in Black women, consistent with the excess risk seen after ductal carcinoma in situ in this group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jnci\/djag048","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:51:08Z","timestamp":1770900668000},"page":"1229-1237","source":"Crossref","is-referenced-by-count":0,"title":["Subsequent breast cancer risk after benign breast biopsy in racially diverse women: Siteman Cancer Center"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9943-2945","authenticated-orcid":false,"given":"Alzina","family":"Koric","sequence":"first","affiliation":[{"name":"Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine , St. Louis, MO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1898-0361","authenticated-orcid":false,"given":"Debbie L","family":"Bennett","sequence":"additional","affiliation":[{"name":"Alvin J. Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine , St. Louis, MO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1921-081X","authenticated-orcid":false,"given":"Fouad","family":"Boulos","sequence":"additional","affiliation":[{"name":"Alvin J. Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine , St. Louis, MO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7307-0291","authenticated-orcid":false,"given":"Graham A","family":"Colditz","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine , St. Louis, MO,","place":["United States"]},{"name":"Alvin J. Siteman Cancer Center, Barnes-Jewish Hospital and Washington University School of Medicine , St. Louis, MO,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"2026070708464211800_djag048-B1","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/cncr.29199","article-title":"Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium","volume":"121","author":"Allison","year":"2015","journal-title":"Cancer"},{"key":"2026070708464211800_djag048-B2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer","volume":"353","author":"Hartmann","year":"2005","journal-title":"N Engl J Med"},{"key":"2026070708464211800_djag048-B3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/jamasurg.2023.6382","article-title":"Benign breast disease and breast cancer risk in the percutaneous biopsy era","volume":"159","author":"Sherman","year":"2024","journal-title":"JAMA Surg"},{"key":"2026070708464211800_djag048-B4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10549-017-4347-9","article-title":"Association between lifestyle, menstrual\/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease","volume":"165","author":"Arthur","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"2026070708464211800_djag048-B5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41523-021-00225-9","article-title":"The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease","volume":"7","author":"Beca","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"2026070708464211800_djag048-B6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13058-021-01410-1","article-title":"Risk factors for breast cancer development by tumor characteristics among women with benign breast disease","volume":"23","author":"Figueroa","year":"2021","journal-title":"Breast Cancer Res"},{"key":"2026070708464211800_djag048-B7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1001\/jamaoncol.2016.3022","article-title":"Subsequent breast cancer risk following diagnosis of atypical ductal hyperplasia on needle biopsy","volume":"3","author":"Menes","year":"2017","journal-title":"JAMA Oncol"},{"key":"2026070708464211800_djag048-B8","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.3390\/ijerph19052625","article-title":"Long-term risk of breast cancer after diagnosis of benign breast disease by screening mammography","volume":"19","author":"Roman","year":"2022","journal-title":"IJERPH"},{"key":"2026070708464211800_djag048-B9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/cncr.29766","article-title":"Clinicopathologic features of breast cancers that develop in women with previous benign breast disease","volume":"122","author":"Visscher","year":"2016","journal-title":"Cancer"},{"key":"2026070708464211800_djag048-B10","year":"2024"},{"key":"2026070708464211800_djag048-B11","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/jama.267.7.941","article-title":"A prospective-study of benign breast disease and the risk of breast-cancer","volume":"267","author":"London","year":"1992","journal-title":"JAMA"},{"key":"2026070708464211800_djag048-B12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10549-014-3208-z","article-title":"Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program","volume":"149","author":"Castells","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"2026070708464211800_djag048-B13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/cncr.22408","article-title":"Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses\u2019 Health Study","volume":"109","author":"Collins","year":"2007","journal-title":"Cancer"},{"key":"2026070708464211800_djag048-B14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s10552-010-9508-7","article-title":"A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer","volume":"21","author":"Kabat","year":"2010","journal-title":"Cancer Causes Control"},{"key":"2026070708464211800_djag048-B15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41523-024-00703-w","article-title":"A systematic review of determinants of breast cancer risk among women with benign breast disease","volume":"11","author":"Burke","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"2026070708464211800_djag048-B16","doi-asserted-by":"publisher","DOI":"10.17226\/27913","volume-title":"Rethinking Race and Ethnicity in Biomedical Research","author":"Wilson","year":"2024"},{"key":"2026070708464211800_djag048-B17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10552-022-01554-1","article-title":"Joanne Knight Breast Health Cohort at Siteman Cancer Center","volume":"33","author":"Colditz","year":"2022","journal-title":"Cancer Causes & Control"},{"key":"2026070708464211800_djag048-B18","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/1097-0142(19930215)71:4&lt;1258::aid-cncr2820710415&gt;3.0.co;2-i","article-title":"Breast cancer risk associated with proliferative breast disease and atypical hyperplasia","volume":"71","author":"Dupont","year":"1993","journal-title":"Cancer"},{"key":"2026070708464211800_djag048-B19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/oxfordjournals.aje.a113598","article-title":"Cigarette smoking, relative weight, and menopause","volume":"117","author":"Willett","year":"1983","journal-title":"Am J Epidemiol"},{"key":"2026070708464211800_djag048-B20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.diii.2017.01.001","article-title":"BI-RADS\u00ae fifth edition: a summary of changes","volume":"98","author":"Spak","year":"2017","journal-title":"Diagn Interv Imaging"},{"key":"2026070708464211800_djag048-B21","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"2026070708464211800_djag048-B22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1536867X0900900206","article-title":"Further development of flexible parametric models for survival analysis","volume":"9","author":"Lambert","year":"2009","journal-title":"Stata J"},{"key":"2026070708464211800_djag048-B23","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1349-7006.1999.tb00789.x","article-title":"Risk of breast cancer in Japanese women with benign breast disease","volume":"90","author":"Minami","year":"1999","journal-title":"Jpn J Cancer Res"},{"key":"2026070708464211800_djag048-B24","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1349-7006.1993.tb00181.x","article-title":"Benign breast disease as a breast cancer risk in Japanese women","volume":"84","author":"Nomura","year":"1993","journal-title":"Jpn J Cancer Res"},{"key":"2026070708464211800_djag048-B25","doi-asserted-by":"publisher","first-page":"1410819","DOI":"10.3389\/fonc.2024.1410819","article-title":"Multiplicity of benign breast disease lesions and breast cancer risk in African American women","volume":"14","author":"Patil","year":"2024","journal-title":"Front Oncol"},{"key":"2026070708464211800_djag048-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-008-0198-8","article-title":"Risk factors for breast cancer from benign breast disease in a diverse population","volume":"118","author":"Worsham","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"2026070708464211800_djag048-B27","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.1158\/1078-0432.CCR-07-0928","article-title":"Multiplicity of benign breast lesions is a risk factor for progression to breast cancer","volume":"13","author":"Worsham","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2026070708464211800_djag048-B28","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/1940-6207.CAPR-12-0175","article-title":"Benign breast disease and the risk of subsequent breast cancer in African American women","volume":"5","author":"Cote","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"2026070708464211800_djag048-B29","first-page":"297","article-title":"Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types","volume":"6","author":"Marshall","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026070708464211800_djag048-B30","doi-asserted-by":"crossref","first-page":"e70164","DOI":"10.1002\/cncr.70164","article-title":"Race-related subsequent breast events after ductal carcinoma in situ: a Surveillance, Epidemiology, and End Results\u2013based analysis","volume":"131","author":"Koric","year":"2025","journal-title":"Cancer"},{"key":"2026070708464211800_djag048-B31","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1002\/cncr.32200","article-title":"Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ","volume":"125","author":"Liu","year":"2019","journal-title":"Cancer"},{"key":"2026070708464211800_djag048-B32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13058-024-01885-8","article-title":"Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome","volume":"26","author":"Strand","year":"2024","journal-title":"Breast Cancer Res"},{"key":"2026070708464211800_djag048-B33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s11524-008-9301-z","article-title":"Racial and geographic differences in mammography screening in St. Louis City: a multilevel study","volume":"85","author":"Lian","year":"2008","journal-title":"J Urban Health"},{"key":"2026070708464211800_djag048-B34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-06-0394","article-title":"Benign breast biopsy diagnosis and subsequent risk of breast cancer","volume":"16","author":"Ashbeck","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026070708464211800_djag048-B35","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/ijc.33680","article-title":"Can breast cancer be stopped? Modifiable risk factors of breast cancer among women with a prior benign or premalignant lesion","volume":"149","author":"Lilleborge","year":"2021","journal-title":"Int J Cancer"},{"key":"2026070708464211800_djag048-B36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1245\/s10434-010-1340-5","article-title":"Predictors of breast cancer development in women with atypical ductal hyperplasia and atypical lobular hyperplasia","volume":"18","author":"Whiffen","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"2026070708464211800_djag048-B37","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/cncr.21763","article-title":"Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease","volume":"106","author":"Gallicchio","year":"2006","journal-title":"Cancer"},{"key":"2026070708464211800_djag048-B38","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/cncr.22136","article-title":"The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses\u2019 Health Study","volume":"107","author":"Collins","year":"2006","journal-title":"Cancer"},{"key":"2026070708464211800_djag048-B39","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11&lt;2698::aid-cncr2820551127&gt;3.0.co;2-a","article-title":"Atypical hyperplastic lesions of the female breast. A long-term follow-up study","volume":"55","author":"Page","year":"1985","journal-title":"Cancer"},{"key":"2026070708464211800_djag048-B40","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1200\/JCO.2007.14.8833","article-title":"Assessment of the accuracy of the Gail model in women with atypical hyperplasia","volume":"26","author":"Pankratz","year":"2008","journal-title":"J Clin Oncol"},{"key":"2026070708464211800_djag048-B41","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1158\/1055-9965.EPI-24-0204","article-title":"Understanding benign breast disease and subsequent breast cancer in Hispanic White females: a step closer to evidence-based management","volume":"33","author":"Lohani","year":"2024","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026070708464211800_djag048-B42","doi-asserted-by":"publisher","first-page":"4944","DOI":"10.1002\/cncr.25386","article-title":"Evaluation of a breast cancer risk prediction model expanded to include category of prior benign breast disease lesion","volume":"116","author":"Tamimi","year":"2010","journal-title":"Cancer"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djag048\/66938187\/djag048.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/7\/1229\/66938187\/djag048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/7\/1229\/66938187\/djag048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:48:33Z","timestamp":1783428513000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/118\/7\/1229\/8487766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,2,16]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djag048","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,2,16]]}}}